A cross-sectional descriptive study: Evaluation of pharmaceutical marketing materials in implementing world health organization guidelines.

VINAYAK JOSHUA 1 and SHREELAKSHMIDEVI S 2, *

1 Department of Internal Medicine, Windsor University School of Medicine, Chicago, USA.
2 Professor, Department of Pharmacology, Windsor University School of Medicine, St. Kitts and Nevis.
 
Research Article
International Journal of Science and Research Archive, 2024, 13(01), 644–649.
Article DOI: 10.30574/ijsra.2024.13.1.1722
Publication history: 
Received on 05 August 2024; revised on 13 September 2024; accepted on 16 September 2024
 
Abstract: 
Pharmaceutical companies employ numerous methods for drug marketing like Advertisements in journals, Videos, Flyers, Books, gifts, Drug promotion literatures and flip charts. In the current study 176 DPL were collected. The DPL were analyzed and categorized in accord to the class of drug promoted to study on the most advertised group of drugs. All the DPL were evaluated for fulfilling WHO guidelines. Antimicrobials were the most promoted followed by cardio-vascular agents and drugs for Gastro-intestinal disorders. Out of 176 DPL collected 96.59% had the active ingredient per dosage/ regimen mentioned. The side effects and major adverse drug reaction were quoted only in 27.27% of DPL. The DPL analyzed in the study had brand names, active ingredient and the therapeutic uses but lagged the information in regard to side effects, contraindications and drug interactions. DPL provides knowledge about newer drug molecules hence providing details about its contraindications and precautions will lead to safer treatment to patients. With combined effort of industries and medical practitioners; ethical drug promotions can become a part of drug marketing.
 
Keywords: 
Drug promotion literatures (DPL); Drug Category; Pharmaceutical marketing; WHO guidelines; prescription
 
Full text article in PDF: 
 
Copyright information: 

Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0